Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04449510 · ClinicalTrials.gov registry record · NA

Short-Term Cardiovascular Effects of E-Cigarettes: Influence of E-Liquid pH

A NA study of Nicotine Dependence and Cardiovascular Risk Factor, sponsored by University of California, San Francisco.

Completed
Registry status
NA
Development phase
14
Enrollment target
2
Study locations

NCT04449510 is a NA study of Nicotine Dependence and Cardiovascular Risk Factor that has completed, run by University of California, San Francisco. The registered enrollment target is 14 participants, below the 187-participant average among 67 other Nicotine Dependence trials with a reported enrollment target (93% lower). The trial reports 2 study locations across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04449510, a NA study of Nicotine Dependence and Cardiovascular Risk Factor, has completed, sponsored by University of California, San Francisco.

COMPLETED
Registry status
NA
Development phase
14 participants
Enrollment target
2
Study locations

Study Summary

This study will examine the short-term cardiovascular (CV) effects of e-liquid pH in a randomized, crossover clinical and behavioral pharmacology study of experienced adult e-cigarette users (N=21). The specific aim is to determine the impact of e-cigarette pH levels on nicotine pharmacology, systemic exposure to toxic volatile organic compounds (VOCs), and short-term cardiovascular effects.

Interventions

  • OTHER Electronic Cigarette

Study Locations (2)

California

  • Zuckerberg San Francisco General Hospital - San Francisco
  • University of California, San Francisco - San Francisco

Trial Details

FieldValue
Enrollment Target 14 participants
Start Date 2021-01-04
Est. Completion 2024-07-31
Phase NA

What the Registry Record Tells You About NCT04449510

The ClinicalTrials.gov registry entry for NCT04449510 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 14 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 187-participant average among 67 other Nicotine Dependence trials with a reported enrollment target (93% lower). The listed sponsor is University of California, San Francisco, which has 1,713 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Nicotine Dependence appearing as the primary indexed condition, and to 1 intervention - of which Electronic Cigarette is the first listed.

NCT04449510 reports 2 study locations spanning 1 distinct geographic area - top geographies include California.

Frequently Asked Questions

What is clinical trial NCT04449510 about?

NCT04449510 is a clinical study titled "Short-Term Cardiovascular Effects of E-Cigarettes: Influence of E-Liquid pH". This study will examine the short-term cardiovascular (CV) effects of e-liquid pH in a randomized, crossover clinical and behavioral pharmacology study of experienced adult e-cigarette users (N=21). The specific aim is to determine the impact of e-cigarette pH levels on nicotine pharmacology, system...

What is the current status of trial NCT04449510?

This trial is currently completed. It is a NA study. The enrollment target is 14 participants. The study started on 2021-01-04. Estimated completion is 2024-07-31.

What conditions does trial NCT04449510 study?

This clinical trial studies the following conditions: Nicotine Dependence, Cardiovascular Risk Factor.

What interventions are being tested in trial NCT04449510?

The interventions under investigation include: Electronic Cigarette (OTHER).

Who is sponsoring clinical trial NCT04449510?

This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04449510 being conducted?

This trial has 2 study locations across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Nicotine Dependence

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.